Table of Content

1 Study Coverage
1.1 GP Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global GP Vaccination Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global GP Vaccination Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global GP Vaccination Sales Estimates and Forecasts 2018-2029
2.2 Global GP Vaccination Revenue by Region
2.2.1 Global GP Vaccination Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global GP Vaccination Revenue by Region (2018-2024)
2.2.3 Global GP Vaccination Revenue by Region (2024-2029)
2.2.4 Global GP Vaccination Revenue Market Share by Region (2018-2029)
2.3 Global GP Vaccination Sales Estimates and Forecasts 2018-2029
2.4 Global GP Vaccination Sales by Region
2.4.1 Global GP Vaccination Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global GP Vaccination Sales by Region (2018-2024)
2.4.3 Global GP Vaccination Sales by Region (2024-2029)
2.4.4 Global GP Vaccination Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global GP Vaccination Sales by Manufacturers
3.1.1 Global GP Vaccination Sales by Manufacturers (2018-2024)
3.1.2 Global GP Vaccination Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GP Vaccination in 2022
3.2 Global GP Vaccination Revenue by Manufacturers
3.2.1 Global GP Vaccination Revenue by Manufacturers (2018-2024)
3.2.2 Global GP Vaccination Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by GP Vaccination Revenue in 2022
3.3 Global Key Players of GP Vaccination, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global GP Vaccination Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global GP Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of GP Vaccination, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of GP Vaccination, Product Offered and Application
3.8 Global Key Manufacturers of GP Vaccination, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global GP Vaccination Sales by Type
4.1.1 Global GP Vaccination Historical Sales by Type (2018-2024)
4.1.2 Global GP Vaccination Forecasted Sales by Type (2024-2029)
4.1.3 Global GP Vaccination Sales Market Share by Type (2018-2029)
4.2 Global GP Vaccination Revenue by Type
4.2.1 Global GP Vaccination Historical Revenue by Type (2018-2024)
4.2.2 Global GP Vaccination Forecasted Revenue by Type (2024-2029)
4.2.3 Global GP Vaccination Revenue Market Share by Type (2018-2029)
4.3 Global GP Vaccination Price by Type
4.3.1 Global GP Vaccination Price by Type (2018-2024)
4.3.2 Global GP Vaccination Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global GP Vaccination Sales by Application
5.1.1 Global GP Vaccination Historical Sales by Application (2018-2024)
5.1.2 Global GP Vaccination Forecasted Sales by Application (2024-2029)
5.1.3 Global GP Vaccination Sales Market Share by Application (2018-2029)
5.2 Global GP Vaccination Revenue by Application
5.2.1 Global GP Vaccination Historical Revenue by Application (2018-2024)
5.2.2 Global GP Vaccination Forecasted Revenue by Application (2024-2029)
5.2.3 Global GP Vaccination Revenue Market Share by Application (2018-2029)
5.3 Global GP Vaccination Price by Application
5.3.1 Global GP Vaccination Price by Application (2018-2024)
5.3.2 Global GP Vaccination Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada GP Vaccination Market Size by Type
6.1.1 US & Canada GP Vaccination Sales by Type (2018-2029)
6.1.2 US & Canada GP Vaccination Revenue by Type (2018-2029)
6.2 US & Canada GP Vaccination Market Size by Application
6.2.1 US & Canada GP Vaccination Sales by Application (2018-2029)
6.2.2 US & Canada GP Vaccination Revenue by Application (2018-2029)
6.3 US & Canada GP Vaccination Market Size by Country
6.3.1 US & Canada GP Vaccination Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada GP Vaccination Sales by Country (2018-2029)
6.3.3 US & Canada GP Vaccination Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe GP Vaccination Market Size by Type
7.1.1 Europe GP Vaccination Sales by Type (2018-2029)
7.1.2 Europe GP Vaccination Revenue by Type (2018-2029)
7.2 Europe GP Vaccination Market Size by Application
7.2.1 Europe GP Vaccination Sales by Application (2018-2029)
7.2.2 Europe GP Vaccination Revenue by Application (2018-2029)
7.3 Europe GP Vaccination Market Size by Country
7.3.1 Europe GP Vaccination Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe GP Vaccination Sales by Country (2018-2029)
7.3.3 Europe GP Vaccination Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China GP Vaccination Market Size
8.1.1 China GP Vaccination Sales (2018-2029)
8.1.2 China GP Vaccination Revenue (2018-2029)
8.2 China GP Vaccination Market Size by Application
8.2.1 China GP Vaccination Sales by Application (2018-2029)
8.2.2 China GP Vaccination Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia GP Vaccination Market Size by Type
9.1.1 Asia GP Vaccination Sales by Type (2018-2029)
9.1.2 Asia GP Vaccination Revenue by Type (2018-2029)
9.2 Asia GP Vaccination Market Size by Application
9.2.1 Asia GP Vaccination Sales by Application (2018-2029)
9.2.2 Asia GP Vaccination Revenue by Application (2018-2029)
9.3 Asia GP Vaccination Sales by Region
9.3.1 Asia GP Vaccination Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia GP Vaccination Revenue by Region (2018-2029)
9.3.3 Asia GP Vaccination Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America GP Vaccination Market Size by Type
10.1.1 Middle East, Africa and Latin America GP Vaccination Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America GP Vaccination Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America GP Vaccination Market Size by Application
10.2.1 Middle East, Africa and Latin America GP Vaccination Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America GP Vaccination Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America GP Vaccination Sales by Country
10.3.1 Middle East, Africa and Latin America GP Vaccination Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America GP Vaccination Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America GP Vaccination Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Moderna
11.1.1 Moderna Company Information
11.1.2 Moderna Overview
11.1.3 Moderna GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Moderna GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Recent Developments
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Company Information
11.2.2 CanSino Biologicals Overview
11.2.3 CanSino Biologicals GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CanSino Biologicals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CanSino Biologicals Recent Developments
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Information
11.3.2 Inovio Pharmaceuticals Overview
11.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Inovio Pharmaceuticals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Inovio Pharmaceuticals Recent Developments
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Company Information
11.4.2 Shenzhen Geno-Immune Medical Institute Overview
11.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Company Information
11.5.2 GlaxoSmithKine Overview
11.5.3 GlaxoSmithKine GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 GlaxoSmithKine GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKine Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Pfizer GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Company Information
11.7.2 Johnson＆Johnson Overview
11.7.3 Johnson＆Johnson GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Johnson＆Johnson GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson＆Johnson Recent Developments
11.8 Heat Biologics
11.8.1 Heat Biologics Company Information
11.8.2 Heat Biologics Overview
11.8.3 Heat Biologics GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Heat Biologics GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Heat Biologics Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Overview
11.9.3 Sanofi GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sanofi GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Takis Biotech
11.10.1 Takis Biotech Company Information
11.10.2 Takis Biotech Overview
11.10.3 Takis Biotech GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Takis Biotech GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takis Biotech Recent Developments
11.11 Zydus Cadila
11.11.1 Zydus Cadila Company Information
11.11.2 Zydus Cadila Overview
11.11.3 Zydus Cadila GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Zydus Cadila GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zydus Cadila Recent Developments
11.12 Codagenix
11.12.1 Codagenix Company Information
11.12.2 Codagenix Overview
11.12.3 Codagenix GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Codagenix GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Codagenix Recent Developments
11.13 GeoVax
11.13.1 GeoVax Company Information
11.13.2 GeoVax Overview
11.13.3 GeoVax GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 GeoVax GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 GeoVax Recent Developments
11.14 Bravovax
11.14.1 Bravovax Company Information
11.14.2 Bravovax Overview
11.14.3 Bravovax GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Bravovax GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bravovax Recent Developments
11.15 Altimmune
11.15.1 Altimmune Company Information
11.15.2 Altimmune Overview
11.15.3 Altimmune GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Altimmune GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Altimmune Recent Developments
11.16 Vaxart
11.16.1 Vaxart Company Information
11.16.2 Vaxart Overview
11.16.3 Vaxart GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Vaxart GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Vaxart Recent Developments
11.17 Clover Biopharmaceuticals
11.17.1 Clover Biopharmaceuticals Company Information
11.17.2 Clover Biopharmaceuticals Overview
11.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Clover Biopharmaceuticals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Clover Biopharmaceuticals Recent Developments
11.18 ImmunoPrecise
11.18.1 ImmunoPrecise Company Information
11.18.2 ImmunoPrecise Overview
11.18.3 ImmunoPrecise GP Vaccination Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 ImmunoPrecise GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ImmunoPrecise Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 GP Vaccination Industry Chain Analysis
12.2 GP Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GP Vaccination Production Mode & Process
12.4 GP Vaccination Sales and Marketing
12.4.1 GP Vaccination Sales Channels
12.4.2 GP Vaccination Distributors
12.5 GP Vaccination Customers
13 Market Dynamics
13.1 GP Vaccination Industry Trends
13.2 GP Vaccination Market Drivers
13.3 GP Vaccination Market Challenges
13.4 GP Vaccination Market Restraints
14 Key Findings in The Global GP Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global GP Vaccination Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of DNA
Table 3. Major Manufacturers of Non-replicating Viral Vector
Table 4. Major Manufacturers of Protein Subunit
Table 5. Major Manufacturers of RNA
Table 6. Major Manufacturers of Others
Table 7. Global GP Vaccination Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global GP Vaccination Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global GP Vaccination Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global GP Vaccination Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global GP Vaccination Revenue Market Share by Region (2018-2024)
Table 12. Global GP Vaccination Revenue Market Share by Region (2024-2029)
Table 13. Global GP Vaccination Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global GP Vaccination Sales by Region (2018-2024) & (K Units)
Table 15. Global GP Vaccination Sales by Region (2024-2029) & (K Units)
Table 16. Global GP Vaccination Sales Market Share by Region (2018-2024)
Table 17. Global GP Vaccination Sales Market Share by Region (2024-2029)
Table 18. Global GP Vaccination Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global GP Vaccination Sales Share by Manufacturers (2018-2024)
Table 20. Global GP Vaccination Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global GP Vaccination Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of GP Vaccination, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. GP Vaccination Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global GP Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global GP Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GP Vaccination as of 2022)
Table 26. Global Key Manufacturers of GP Vaccination, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of GP Vaccination, Product Offered and Application
Table 28. Global Key Manufacturers of GP Vaccination, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global GP Vaccination Sales by Type (2018-2024) & (K Units)
Table 31. Global GP Vaccination Sales by Type (2024-2029) & (K Units)
Table 32. Global GP Vaccination Sales Share by Type (2018-2024)
Table 33. Global GP Vaccination Sales Share by Type (2024-2029)
Table 34. Global GP Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global GP Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global GP Vaccination Revenue Share by Type (2018-2024)
Table 37. Global GP Vaccination Revenue Share by Type (2024-2029)
Table 38. GP Vaccination Price by Type (2018-2024) & (US$/Unit)
Table 39. Global GP Vaccination Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global GP Vaccination Sales by Application (2018-2024) & (K Units)
Table 41. Global GP Vaccination Sales by Application (2024-2029) & (K Units)
Table 42. Global GP Vaccination Sales Share by Application (2018-2024)
Table 43. Global GP Vaccination Sales Share by Application (2024-2029)
Table 44. Global GP Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global GP Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global GP Vaccination Revenue Share by Application (2018-2024)
Table 47. Global GP Vaccination Revenue Share by Application (2024-2029)
Table 48. GP Vaccination Price by Application (2018-2024) & (US$/Unit)
Table 49. Global GP Vaccination Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada GP Vaccination Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada GP Vaccination Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada GP Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada GP Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada GP Vaccination Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada GP Vaccination Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada GP Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada GP Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada GP Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada GP Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada GP Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 63. Europe GP Vaccination Sales by Type (2018-2024) & (K Units)
Table 64. Europe GP Vaccination Sales by Type (2024-2029) & (K Units)
Table 65. Europe GP Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe GP Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe GP Vaccination Sales by Application (2018-2024) & (K Units)
Table 68. Europe GP Vaccination Sales by Application (2024-2029) & (K Units)
Table 69. Europe GP Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe GP Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe GP Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe GP Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe GP Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 75. Europe GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 76. China GP Vaccination Sales by Type (2018-2024) & (K Units)
Table 77. China GP Vaccination Sales by Type (2024-2029) & (K Units)
Table 78. China GP Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 79. China GP Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 80. China GP Vaccination Sales by Application (2018-2024) & (K Units)
Table 81. China GP Vaccination Sales by Application (2024-2029) & (K Units)
Table 82. China GP Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 83. China GP Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia GP Vaccination Sales by Type (2018-2024) & (K Units)
Table 85. Asia GP Vaccination Sales by Type (2024-2029) & (K Units)
Table 86. Asia GP Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia GP Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia GP Vaccination Sales by Application (2018-2024) & (K Units)
Table 89. Asia GP Vaccination Sales by Application (2024-2029) & (K Units)
Table 90. Asia GP Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia GP Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia GP Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia GP Vaccination Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia GP Vaccination Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia GP Vaccination Sales by Region (2018-2024) & (K Units)
Table 96. Asia GP Vaccination Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America GP Vaccination Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America GP Vaccination Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America GP Vaccination Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America GP Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America GP Vaccination Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America GP Vaccination Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America GP Vaccination Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America GP Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America GP Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America GP Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America GP Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 110. Moderna Company Information
Table 111. Moderna Description and Major Businesses
Table 112. Moderna GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Moderna GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Moderna Recent Developments
Table 115. CanSino Biologicals Company Information
Table 116. CanSino Biologicals Description and Major Businesses
Table 117. CanSino Biologicals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. CanSino Biologicals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. CanSino Biologicals Recent Developments
Table 120. Inovio Pharmaceuticals Company Information
Table 121. Inovio Pharmaceuticals Description and Major Businesses
Table 122. Inovio Pharmaceuticals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Inovio Pharmaceuticals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Inovio Pharmaceuticals Recent Developments
Table 125. Shenzhen Geno-Immune Medical Institute Company Information
Table 126. Shenzhen Geno-Immune Medical Institute Description and Major Businesses
Table 127. Shenzhen Geno-Immune Medical Institute GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Shenzhen Geno-Immune Medical Institute GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Shenzhen Geno-Immune Medical Institute Recent Developments
Table 130. GlaxoSmithKine Company Information
Table 131. GlaxoSmithKine Description and Major Businesses
Table 132. GlaxoSmithKine GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. GlaxoSmithKine GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. GlaxoSmithKine Recent Developments
Table 135. Pfizer Company Information
Table 136. Pfizer Description and Major Businesses
Table 137. Pfizer GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Pfizer GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Pfizer Recent Developments
Table 140. Johnson＆Johnson Company Information
Table 141. Johnson＆Johnson Description and Major Businesses
Table 142. Johnson＆Johnson GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Johnson＆Johnson GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Johnson＆Johnson Recent Developments
Table 145. Heat Biologics Company Information
Table 146. Heat Biologics Description and Major Businesses
Table 147. Heat Biologics GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Heat Biologics GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Heat Biologics Recent Developments
Table 150. Sanofi Company Information
Table 151. Sanofi Description and Major Businesses
Table 152. Sanofi GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Sanofi GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Sanofi Recent Developments
Table 155. Takis Biotech Company Information
Table 156. Takis Biotech Description and Major Businesses
Table 157. Takis Biotech GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Takis Biotech GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Takis Biotech Recent Developments
Table 160. Zydus Cadila Company Information
Table 161. Zydus Cadila Description and Major Businesses
Table 162. Zydus Cadila GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Zydus Cadila GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Zydus Cadila Recent Developments
Table 165. Codagenix Company Information
Table 166. Codagenix Description and Major Businesses
Table 167. Codagenix GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Codagenix GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Codagenix Recent Developments
Table 170. GeoVax Company Information
Table 171. GeoVax Description and Major Businesses
Table 172. GeoVax GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. GeoVax GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. GeoVax Recent Developments
Table 175. Bravovax Company Information
Table 176. Bravovax Description and Major Businesses
Table 177. Bravovax GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Bravovax GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Bravovax Recent Developments
Table 180. Altimmune Company Information
Table 181. Altimmune Description and Major Businesses
Table 182. Altimmune GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Altimmune GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Altimmune Recent Developments
Table 185. Vaxart Company Information
Table 186. Vaxart Description and Major Businesses
Table 187. Vaxart GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Vaxart GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Vaxart Recent Developments
Table 190. Clover Biopharmaceuticals Company Information
Table 191. Clover Biopharmaceuticals Description and Major Businesses
Table 192. Clover Biopharmaceuticals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Clover Biopharmaceuticals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Clover Biopharmaceuticals Recent Developments
Table 195. ImmunoPrecise Company Information
Table 196. ImmunoPrecise Description and Major Businesses
Table 197. ImmunoPrecise GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 198. ImmunoPrecise GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. ImmunoPrecise Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. GP Vaccination Distributors List
Table 203. GP Vaccination Customers List
Table 204. GP Vaccination Market Trends
Table 205. GP Vaccination Market Drivers
Table 206. GP Vaccination Market Challenges
Table 207. GP Vaccination Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. GP Vaccination Product Picture
Figure 2. Global GP Vaccination Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global GP Vaccination Market Share by Type in 2022 & 2029
Figure 4. DNA Product Picture
Figure 5. Non-replicating Viral Vector Product Picture
Figure 6. Protein Subunit Product Picture
Figure 7. RNA Product Picture
Figure 8. Others Product Picture
Figure 9. Global GP Vaccination Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global GP Vaccination Market Share by Application in 2022 & 2029
Figure 11. Adults
Figure 12. Children
Figure 13. GP Vaccination Report Years Considered
Figure 14. Global GP Vaccination Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global GP Vaccination Revenue 2018-2029 (US$ Million)
Figure 16. Global GP Vaccination Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global GP Vaccination Revenue Market Share by Region (2018-2029)
Figure 18. Global GP Vaccination Sales 2018-2029 ((K Units)
Figure 19. Global GP Vaccination Sales Market Share by Region (2018-2029)
Figure 20. US & Canada GP Vaccination Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada GP Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe GP Vaccination Sales YoY (2018-2029) & (K Units)
Figure 23. Europe GP Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China GP Vaccination Sales YoY (2018-2029) & (K Units)
Figure 25. China GP Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) GP Vaccination Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) GP Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America GP Vaccination Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America GP Vaccination Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The GP Vaccination Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of GP Vaccination in the World: Market Share by GP Vaccination Revenue in 2022
Figure 32. Global GP Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global GP Vaccination Sales Market Share by Type (2018-2029)
Figure 34. Global GP Vaccination Revenue Market Share by Type (2018-2029)
Figure 35. Global GP Vaccination Sales Market Share by Application (2018-2029)
Figure 36. Global GP Vaccination Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada GP Vaccination Sales Market Share by Type (2018-2029)
Figure 38. US & Canada GP Vaccination Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada GP Vaccination Sales Market Share by Application (2018-2029)
Figure 40. US & Canada GP Vaccination Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada GP Vaccination Revenue Share by Country (2018-2029)
Figure 42. US & Canada GP Vaccination Sales Share by Country (2018-2029)
Figure 43. U.S. GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 44. Canada GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 45. Europe GP Vaccination Sales Market Share by Type (2018-2029)
Figure 46. Europe GP Vaccination Revenue Market Share by Type (2018-2029)
Figure 47. Europe GP Vaccination Sales Market Share by Application (2018-2029)
Figure 48. Europe GP Vaccination Revenue Market Share by Application (2018-2029)
Figure 49. Europe GP Vaccination Revenue Share by Country (2018-2029)
Figure 50. Europe GP Vaccination Sales Share by Country (2018-2029)
Figure 51. Germany GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 52. France GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 54. Italy GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 55. Russia GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 56. China GP Vaccination Sales Market Share by Type (2018-2029)
Figure 57. China GP Vaccination Revenue Market Share by Type (2018-2029)
Figure 58. China GP Vaccination Sales Market Share by Application (2018-2029)
Figure 59. China GP Vaccination Revenue Market Share by Application (2018-2029)
Figure 60. Asia GP Vaccination Sales Market Share by Type (2018-2029)
Figure 61. Asia GP Vaccination Revenue Market Share by Type (2018-2029)
Figure 62. Asia GP Vaccination Sales Market Share by Application (2018-2029)
Figure 63. Asia GP Vaccination Revenue Market Share by Application (2018-2029)
Figure 64. Asia GP Vaccination Revenue Share by Region (2018-2029)
Figure 65. Asia GP Vaccination Sales Share by Region (2018-2029)
Figure 66. Japan GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 70. India GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America GP Vaccination Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America GP Vaccination Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America GP Vaccination Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America GP Vaccination Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America GP Vaccination Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America GP Vaccination Sales Share by Country (2018-2029)
Figure 77. Brazil GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 80. Israel GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries GP Vaccination Revenue (2018-2029) & (US$ Million)
Figure 82. GP Vaccination Value Chain
Figure 83. GP Vaccination Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed